Levbid Tablet, Extended Release
Product Images NDC 68220-115

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Levbid (NDC 68220-115). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Viatris Specialty Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Levbid Extended-release Tablets Bottle Label (Image 01)

Levbid Extended-release Tablets Bottle Label (Image 01)
Label for Levbid extended-release tablets containing hyoscyamine sulfate 0.375 mg. The oral tablet is for prescription use only, supplied by Alaven Pharmaceutical LLC. The package contains 100 tablets. The label includes storage instructions, dosage guidance, and contact information for medical inquiries.*
FDA Label Image

Chemical Structure (Levbid 01)

Chemical Structure (Levbid 01)
Chemical structure of hyoscyamine sulfate dihydrate, the active ingredient in Levbid tablets.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.